Opportunistic Infections Citation List:
January 20 - February 2, 2012
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
1. Antimycobacterial and Antioxidant Activities of Reserpine and Its Derivatives. Begum, S., S.Q. Naqvi, A. Ahmed, S. Tauseef, and B.S. Siddiqui. Natural Product Research, 2012. [Epub ahead of print]; PMID[22273392].
[PubMed]. OI_0120-020212.
2. Synthesis and Antitubercular Activity of Novel Amino acid Derivatives. Da Costa, C.F., A.C. Pinheiro, M.V. De Almeida, M.C. Lourenco, and M.V. De Souza. Chemical Biology & Drug Design, 2012. 79(2): p. 216-222; PMID[22078007].
[PubMed]. OI_0120-020212.
3. Synthesis and in Vitro Antimycobacterial Activity of Compounds Derived from (R)- and (S)-2-Amino-1-butanol - the Crucial Role of the Configuration. Dobrikov, G.M., V. Valcheva, M. Stoilova-Disheva, G. Momekov, P. Tzvetkova, A. Chimov, and V. Dimitrov. European Journal of Medicinal Chemistry, 2012. 48: p. 45-56; PMID[22154833].
[PubMed]. OI_0120-020212.
4. Phenylethyl Butyrate Enhances the Potency of Second-line Drugs against Clinical Isolates of Mycobacterium tuberculosis. Grau, T., P. Selchow, M. Tigges, R. Burri, M. Gitzinger, E.C. Bottger, M. Fussenegger, and P. Sander. Antimicrobial Agents and Chemotherapy, 2012. 56(2): p. 1142-1145; PMID[22106218].
[PubMed]. OI_0120-020212.
5. Novel Trisubstituted benzimidazoles, Targeting Mtb Ftsz, as a New Class of Antitubercular Agents. Kumar, K., D. Awasthi, S.Y. Lee, I. Zanardi, B. Ruzsicska, S. Knudson, P.J. Tonge, R.A. Slayden, and I. Ojima. Journal of Medicinal Chemistry, 2011. 54(1): p. 374-381; PMID[21126020].
[PubMed]. OI_0120-020212.
6. An Antibacterial from Hypericum Acmosepalum Inhibits ATP-dependent Mure Ligase from Mycobacterium tuberculosis. Osman, K., D. Evangelopoulos, C. Basavannacharya, A. Gupta, T.D. McHugh, S. Bhakta, and S. Gibbons. International Journal of Antimicrobial Agents, 2012. 39(2): p. 124-129; PMID[22079533].
[PubMed]. OI_0120-020212.
7. The Cathelicidin-like Peptide Derived from Panda Genome Is a Potential Antimicrobial Peptide. Yan, X., J. Zhong, H. Liu, C. Liu, K. Zhang, and R. Lai. Gene, 2012. 492(2): p. 368-374; PMID[22101189].
[PubMed]. OI_0120-020212.
8. Synthesis, Structure and Biological Evaluation of Novel Bicyclic Nitroimidazole Derivatives. Zaprutko, L., J. Zwawiak, E. Augustynowicz-Kopec, Z. Zwolska, E. Bartoszak-Adamska, and W. Nowicki. Archiv Der Pharmazie, 2012. [Epub ahead of print]; PMID[22266946].
[PubMed]. OI_0120-020212.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
9. Synthesis and Antimalarial Activity of Dihydroperoxides and Tetraoxanes Conjugated with bis(Benzyl)acetone Derivatives. Franco, L.L., M.V. de Almeida, E.S. LF, P.P. Vieira, A.M. Pohlit, and M.S. Valle. Chemical Biology & Drug Design, 2012. [Epub ahead of print]; PMID[22284812].
[PubMed]. OI_0120-020212.
10. In Vitro Antiplasmodial Effect of Ethanolic Extracts of Traditional Medicinal Plant Ocimum Species against Plasmodium falciparum. Inbaneson, S.J., R. Sundaram, and P. Suganthi. Asian Pacific Journal of Tropical Medicine, 2012. 5(2): p. 103-106; PMID[22221750].
[PubMed]. OI_0120-020212.
11. Synthesis of Purine N(9)-[2-hydroxy-3-O-(phosphonomethoxy)propyl] Derivatives and Their Side-Chain Modified Analogs as Potential Antimalarial Agents. Krecmerova, M., M. Dracinsky, D. Hockova, A. Holy, D.T. Keough, and L.W. Guddat. Bioorganic & Medicinal Chemistry, 2012. 20(3): p. 1222-1230; PMID[22249123].
[PubMed]. OI_0120-020212.
12. Antimalarial Activity of 9a-N Substituted 15-Membered Azalides with Improved in Vitro and in Vivo Activity over Azithromycin. Peric, M., A. Fajdetic, R. Rupcic, S. Alihodzic, D. Ziher, M. Bukvic Krajacic, K.S. Smith, Z. Ivezic-Schonfeld, J. Padovan, G. Landek, D. Jelic, A. Hutinec, M. Mesic, A. Ager, W.Y. Ellis, W.K. Milhous, C. Ohrt, and R. Spaventi. Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22148880].
[PubMed]. OI_0120-020212.
13. Synthesis and Evaluation of 1-Amino-6-halo-beta-carbolines as Antimalarial and Antiprion Agents. Thompson, M.J., J.C. Louth, S.M. Little, M.P. Jackson, Y. Boursereau, B. Chen, and I. Coldham. ChemMedChem, 2012. [Epub ahead of print]; PMID[22275299].
[PubMed]. OI_0120-020212.
14. In Vitro Anti-plasmodial Activity of Some Traditionally Used Medicinal Plants against Plasmodium falciparum. Venkatesalu, V., N. Gopalan, C.R. Pillai, V. Singh, M. Chandrasekaran, A. Senthilkumar, and N. Chandramouli. Parasitology Research, 2012. [Epub ahead of print]; PMID[22290450].
[PubMed]. OI_0120-020212.
15. In Vitro and in Vivo Activity of Solithromycin (Cem-101) against Plasmodium Species. Wittlin, S., E. Ekland, J.C. Craft, J. Lotharius, I. Bathurst, D.A. Fidock, and P. Fernandes. Antimicrobial Agents and Chemotherapy, 2012. 56(2): p. 703-707; PMID[22083475].
[PubMed]. OI_0120-020212.
16. Benzoxaborole Antimalarial Agents. Part 2: Discovery of Fluoro-substituted 7-(2-Carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles. Zhang, Y.K., J.J. Plattner, Y.R. Freund, E.E. Easom, Y. Zhou, L. Ye, H. Zhou, D. Waterson, F.J. Gamo, L.M. Sanz, M. Ge, Z. Li, L. Li, H. Wang, and H. Cui. Bioorganic & Medicinal Chemistry Letters, 2012. 22(3): p. 1299-1307; PMID[22243961].
[PubMed]. OI_0120-020212.
ANTILEISHMANIAL COMPOUNDS (Leishmania spp.)
17. In Vitro Antileishmanial and Antitrypanosomal Activities of Flavanones from Baccharis retusa DC. (Asteraceae). Grecco Sdos, S., J.Q. Reimao, A.G. Tempone, P. Sartorelli, R.L. Cunha, P. Romoff, M.J. Ferreira, O.A. Favero, and J.H. Lago. Experimental Parasitology, 2012. 130(2): p. 141-145; PMID[22143090].
[PubMed]. OI_0120-020212.
Citations from the ISI Web of Knowledge Listings for O.I.
18. Efficacy of Avicennia marina (Forsk.) Vierh. Leaves Extracts Against Some Atmospheric Fungi. Afzal, M., F.S. Mehdi, F.M. Abbasi, H. Ahmad, R. Masood, Inamullah, J. Alam, G. Jan, M. Islam, N. Ul Amin, A. Majid, M. Fiaz, and A.H. Shah. African Journal of Biotechnology, 2011. 10(52): p. 10790-10794; ISI[000298392900030].
[WOS]. OI_0120-020212.
19. 4-Substituted Thioquinolines and Thiazoloquinolines: Potent, Selective, and Tween-80 in Vitro Dependent Families of Antitubercular Agents with Moderate in Vivo Activity. Escribano, J., C. Rivero-Hernandez, H. Rivera, D. Barros, J. Castro-Pichel, E. Perez-Herran, A. Mendoza-Losana, I. Angulo-Barturen, S. Ferrer-Bazaga, E. Jimenez-Navarro, and L. Ballell. ChemMedChem, 2011. 6(12): p. 2252-2263; ISI[000298563400016].
[WOS]. OI_0120-020212.
20. Ganoderma Lucidum: A Source for Novel Bioactive Lectin. Girjal, V.U., S. Neelagund, and M. Krishnappa. Protein and Peptide Letters, 2011. 18(11): p. 1150-1157; ISI[000298538600012].
[WOS]. OI_0120-020212.
SciFinder citations
21. Benzimidazoles and Pharmaceutical Compositions Thereof. Ojima, I. and S. Lee. Patent. 2008-US05084 20080421, 62 pp.
[Scifinder]. OI_0120-020212.